BeiGene, Ltd. Depreciation & Amortization 2011-2026 | BGNE

Annual Depreciation & Amortization BeiGene, Ltd.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
142 M	172 M	87.7 M	66.3 M	46.5 M	31.8 M	18.6 M	10.4 M	4.76 M	1.91 M	1.54 M	1.56 M	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
172 M	1.54 M	48.7 M

Quarterly Depreciation & Amortization BeiGene, Ltd.

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
35.7 M	29.9 M	32.8 M	-	70 M	23.8 M	25.3 M	-	19.2 M	21.3 M	20 M	-	15.2 M	14.5 M	16.6 M	-	33.3 M	21.2 M	9.63 M	-	24 M	15.6 M	7.75 M	-	11.1 M	7.11 M	3.42 M	-	7.02 M	4.58 M	2.24 M	-	2.7 M	1.4 M	864 K	-	1.44 M	492 K	439 K	-	402 K	373 K	352 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
70 M	352 K	14.5 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Apellis Pharmaceuticals APLS	1.56 M	$ 20.7	-1.24 %	$ 2.61 B	USA
Aptorum Group Limited APM	1.13 M	$ 0.84	-	$ 4.58 M	China
Axsome Therapeutics AXSM	503 K	$ 166.38	-	$ 8.28 B	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
AbCellera Biologics ABCL	18.4 M	$ 3.82	-	$ 1.14 B	Canada
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Capricor Therapeutics CAPR	1.07 M	$ 26.86	-3.83 %	$ 719 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Codexis CDXS	4.95 M	$ 1.02	-	$ 74.9 M	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	13.6 M	$ 3.34	0.3 %	$ 1.2 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Agios Pharmaceuticals AGIO	5.2 M	$ 29.2	-3.41 %	$ 1.69 B	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Alector ALEC	5.72 M	$ 2.21	-9.05 %	$ 228 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	63 K	-	10.36 %	$ 9.8 M	USA
Altimmune ALT	238 K	$ 4.16	-	$ 295 M	USA
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Amarin Corporation plc AMRN	3.02 M	$ 13.93	0.94 %	$ 5.78 B	Irlanda
AbbVie ABBV	762 M	$ 234.26	0.94 %	$ 414 B	USA
Blueprint Medicines Corporation BPMC	16.3 M	-	-	$ 8.14 B	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
AIM ImmunoTech AIM	38 K	$ 0.77	-14.64 %	$ 37 M	USA